For investors · Limited partners

First institutional capital into an overlooked market.

Southeastern Europe trains the engineers and clinicians who build digital health elsewhere. As a Limited Partner you get early access to that market — with a proven team, strategic access to Western buyers and a pipeline already in diligence.

Why back us

Ground presence, entry pricing, a bridge west

Three things a fund needs to make an early-stage position in this region work — and the reasons we built CHEV between two continents rather than in one.

01

Ground presence

Partners split between Manchester, MA and the region. Sourcing and diligence happen in person, through people who live in these markets — not through cold inbound.

02

Entry pricing

A region that produces the talent behind Western digital health, priced years behind the markets that hire it, with grants and tax incentives stretching each round further.

03

A built-in bridge west

Our US base and diaspora network give portfolio companies a direct path to Western buyers, follow-on capital and board-level operators who have made that crossing before.

The thesis in three numbers

Western demand, regional cost base

The math is simple: a team here reaches the same proof point on a fraction of a Western burn — and sells into the same hospital systems.

~3×
Lower engineering cost

Senior software and ML talent at a fraction of US and Western EU salaries, with the same university pipeline.

$1.5T
Digital health market by 2032

Up from about $500B in 2025 as care moves to remote monitoring, telemedicine and clinical AI. Source: Fortune Business Insights.

$10M
Target fund size

A focused first fund — backing 10–12 early-stage teams across the region, small enough to move fast.

How an investment moves

From advisor tip to follow-on

Deals come from people who live in these markets, not from cold inbound — and our support continues long after the investment closes.

{{ stage.title }}
{{ stage.desc }}
Why Southeastern Europe

Overlooked, not underqualified

Exceptional talent, attractive valuations and direct access to Western markets — the three things that make an early-stage position here worth holding.

{{ r.n }}
{{ r.title }}

{{ activeReason }}

{{ activeReasonBody }}

Fund terms
Stage focus
Pre-seed to Series A
Sector focus
Digital health & health tech
Geography
6 countries
Target fund size
$10M
Portfolio
10–12 companies
Fund
Debut (Fund I)
Partners
3
Advisors on call
20+

Full terms are shared with prospective LPs on request.

Who's underwriting this

Twenty-plus advisors run diligence alongside three partners

We do not wait for warm intros. Clinicians, operators and former Silicon Valley engineers native to the region surface founders before they reach anyone else's radar — and it is the same bench that later mentors portfolio companies and opens doors in the West. Meet the full bench →

George Church
Haris Tabakovic
Miralem Salihovic
Namik Hrle
Jelisaveta Ilić
+12 more advisors
Limited partners

Request the data room

Fund materials, pipeline and terms. We are happy to walk through the thesis with you before anything else.